- Filed
- Aug 13, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Aug 11, 2024 | 372.92M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 354.84M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 194.55M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$55.25K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$290.24K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $2.01K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $24.84K |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2024 | −$899.35K |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2023 | −$848.53K |
| Current Liabilities restated | Q1 2024 · Mar 31, 2024 | $946.89K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $831.51K |
| Total Liabilities restated | Q1 2024 · Mar 31, 2024 | $946.89K |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $934K |
| Current Assets | Q1 2024 · Mar 31, 2024 | $13.46K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $41.88K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $14.55K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $85.47K |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense restated | Q1 2024 · Mar 31, 2024 | $23.94K |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $87.5K |
| Net Income restated | Q1 2024 · Mar 31, 2024 | −$135.22K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$950.5K |
| Operating Income restated | Q1 2024 · Mar 31, 2024 | −$108.57K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$474.69K |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $16.62K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $56.59K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $16.5K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $58.87K |